familial cold autoinflammatory syndrome (FCAS)
Jump to navigation
Jump to search
Epidemiology
- rare
- onset < 1 year of age
- affects children of European descent
Pathology
- systemic inflammatory disease
- amyloidosis
Genetics
- autosomal dominant
- mutation in CIAS1 gene
Clinical manifestations
- episodes of rash, arthralgia, fever & conjunctivitis after generalized exposure to cold
- attacks last 12-24 hours
- urticaria-like rash
- nausea
- headache
- sensorineural hearing loss
Management
- interleukin 1-beta inhibitor[2]
- rilonacept
- canakinumab (Ilaris) FDA-approved in 2009
More general terms
Additional terms
References
- ↑ OMIM https://mirror.omim.org/entry/120100
- ↑ 2.0 2.1 Medical Knowledge Self Assessment Program (MKSAP) 16, 17, 18. American College of Physicians, Philadelphia 2012, 2015, 2018